VitMode

MicroAge

A machine-learning model that estimates biological age from the composition of the saliva microbiome — a very early, emerging approach to aging biomarkers, distinct from the mortality-focused OMAA Score.

AKdr Anna KowalczykReviewed by dr Piotr ZielińskiUpdated: September 5, 2026
Early-stage evidence
3.9

Number of studies

2

Safety

High

Time to effects

Not applicable — this is an analytical/research tool, not an intervention producing effects over time.

Who it's for

People following research on aging biomarkers and the microbiomeScience-minded readers interested in new methods of assessing biological age
Table of contents

TL;DR

A machine-learning model that estimates biological age from the composition of the saliva microbiome — a very early, emerging approach to aging biomarkers, distinct from the mortality-focused OMAA Score.

  • A non-invasive method of data collection (a saliva sample instead of blood)
  • Shows that oral microbiome composition carries a measurable signal linked to age and health status in a large, diverse population
  • A potentially useful research direction for further differentiating aging biomarkers independent of blood and DNA
Tool typeMachine-learning model estimating biological age from the saliva microbiome
Research levelEarly-stage — a single publication (2025), no independent replication yet
Data source16S rRNA analysis of the saliva microbiome, over 8,000 microbial features
Training sample size4,532 healthy people from six continents
Key metricMicroAgeGap — the difference between predicted and chronological age
Differs fromOMAA Score — a separate oral-microbiome-based indicator linked to mortality and frailty
StatusResearch tool, not a validated commercially available clinical test

Understand

Overview

MicroAge is the name of a machine-learning model, published in 2025 in the journal iMetaOmics, that uses saliva microbiome composition (16S rRNA gene analysis) to estimate a person's biological age and detect deviations suggesting poorer health. The model was trained on saliva samples from 4,532 healthy people across six continents, using presence and abundance data from more than 8,000 microbial features. It is one of the first 'clocks' of this kind based not on blood or DNA, but on the oral microbiome.

It's worth distinguishing MicroAge right away from the related but distinct concept of the OMAA Score (Oral Microbiome Aging Acceleration Score) — both use the oral microbiome, but serve different purposes. The OMAA Score is an 'aging acceleration' indicator calculated as the difference between predicted and actual age, directly linked to mortality and frailty in a specific research cohort. MicroAge is a broader predictive model, tested primarily for accuracy in age estimation and detecting disease states (the so-called MicroAgeGap — the difference between predicted and chronological age as a signal of health disruption), rather than as a ready-made mortality-risk indicator. In other words, these are two different analytical tools built on a similar type of data, not synonyms.

This field of research is at a very early stage. A single publication, even a methodologically well-designed one, is not the same as a validated, reproducible clinical biomarker. People interested in the biology of aging and the microbiome can treat MicroAge as an interesting research direction showing that oral bacterial composition (and earlier, gut bacterial composition) carries an age-related signal — but not as a validated test available today for self-assessing one's own biological age.

Mechanism of action

The composition of the microbiome — both gut and oral — changes with age in a partly predictable way: certain bacterial groups systematically gain abundance while others decline, and overall microbial diversity shifts as well. Models like MicroAge exploit this relationship statistically — a machine-learning algorithm (in this case compared against methods such as LASSO and elastic net) analyzes thousands of microbial features from a saliva sample and learns to recognize the pattern typical of a given chronological age across a large healthy population.

Once trained, the model can be applied to a new sample and generate a predicted 'microbiome age.' The difference between this value and a person's chronological age (MicroAgeGap) is interpreted as a potential health signal — in the study described, a positive gap was associated with a pro-inflammatory profile, and centenarians consistently had a lower predicted microbiome age than their chronological age would suggest. A key limitation: the model, which explained most of the variance in age in the healthy population (R² ≈ 0.80), performed noticeably worse in populations with disease (R² ≈ 0.16) — showing that the predictive power of such models depends heavily on clinical context and is not universal.

1

Saliva sample collection

Non-invasive sample collection and 16S rRNA gene sequencing to determine oral microbiome composition.

2

Microbial feature extraction

Analysis of the presence and abundance of thousands of bacterial taxa as model input data.

3

Age prediction via the ML model

An algorithm trained on a large, healthy population estimates 'microbiome age' from a pattern typical of a given age group.

4

MicroAgeGap interpretation

The difference between predicted and actual age is analyzed as a potential, preliminary health signal — not a ready-made diagnosis.

Evidence: early-stage — based on 2 studies in this database.

Benefits

A non-invasive method of data collection (a saliva sample instead of blood)
Shows that oral microbiome composition carries a measurable signal linked to age and health status in a large, diverse population
A potentially useful research direction for further differentiating aging biomarkers independent of blood and DNA

Common myths

MythMicroAge and the OMAA Score are the same test under two names.

FactThese are two distinct models built on a similar type of data (oral microbiome) but with different purposes: MicroAge estimates biological age and health deviations (MicroAgeGap), while the OMAA Score is an aging-acceleration indicator directly linked to mortality and frailty in a specific cohort.

MythSince the model predicts age well in a healthy population, it can already be treated as a ready-made diagnostic test.

FactThe model's performance dropped markedly in populations with disease (R² ≈ 0.16 versus ≈ 0.80 in the healthy population), showing the tool needs further validation before clinical use can be discussed.

Check your profile

Not sure which supplements actually make sense for you?

Answer a few short questions about your lifestyle, diet, sleep, and goals. VitMode will build your profile and show supplements worth considering — with reasoning and evidence strength.

Takes about 2 minutesBased on scientific evidence

Recommendations take your answers and the strength of the scientific evidence into account. A supplement's popularity has no bearing on whether it gets recommended.

Practice

Frequently asked questions

It's a machine-learning model (published in 2025 in iMetaOmics) that estimates biological age from saliva microbiome composition, trained on a sample of over 4,500 healthy people.

Both use the oral microbiome, but MicroAge is a general model for predicting age and health status (MicroAgeGap), while the OMAA Score is a separate indicator of aging acceleration directly linked to mortality and frailty in the studied cohort.

There is currently no validated, commercially available clinical test based on this specific model — it's a research tool described in a single scientific publication.

Yes, separate 'clocks' based on the gut microbiome (e.g., the so-called gAge) are being developed in parallel, also linking bacterial composition to age and health status, but these are different models from MicroAge.

No — it's a general statistical signal that in the study was associated with a pro-inflammatory profile or reduced immune function, not a diagnosis of a specific disease.

What to combine with

Good combinations

Gut MicrobiomeBoth areas — the oral and gut microbiome — are studied as independent sources of age-related signal, though they involve different bacterial ecosystems in the body

Safety

Side effects & contraindications

Possible side effects

Contraindications

No significant contraindications at typical doses.

Is it worth taking?

Who it's for

  • People following research on aging biomarkers and the microbiome
  • Science-minded readers interested in new methods of assessing biological age

Not for

  • No significant contraindications at typical doses.

Evidence

Worth knowing

The MicroAge model was trained on saliva samples from 4,532 healthy people across six continents, using over 8,000 microbial features.

Centenarians in the study consistently had a lower predicted microbiome age (MicroAgeGap) than their chronological age would suggest.

Studies

Saliva MicroAge: A salivary microbiome based machine learning model for noninvasive aging assessment and health state prediction

Early-stage evidence

Xu T, Niu Y, Deng C, Cheung Y, Li Y, Hu Z, Sun S, Chen Y, He F, Yang G, Chen F, Duan C, Huang Y, Deng X · iMetaOmics · 2025

The publication introducing the MicroAge model — a machine-learning model trained on 4,532 saliva samples from six continents that predicts biological age from the oral microbiome; performance (R² ≈ 0.80 in the healthy population) dropped to R² ≈ 0.16 in populations with disease.

View study

A gut aging clock using microbiome multi-view profiles is associated with health and frail risk

Early-stage evidence

Wang H, Chen Y, Feng L, Lu S, Zhu J, Zhao J, Zhang H, Chen W, Lu W · Gut Microbes · 2024

A separate but conceptually related model (gAge) based on the gut microbiome, showing that a similar approach to 'microbiome clocks' recurs across different bacterial ecosystems in the body and correlates with health status and frailty risk.

View study

Sources & bibliography

Citations are illustrative for this demo version and require full bibliographic verification by the editorial team before production publication.

Compare with similar entries

About the authors of this entry

AK

Author

dr Anna Kowalczyk

Editor-in-Chief, Molecular Biology

Anna studied molecular biology at the University of Warsaw, then spent eight years after her PhD in a lab researching the mechanisms of cellular aging and autophagy. She stumbled into science journalism almost by accident — frustrated by how easily her field's findings get oversimplified in the media, she started a blog explaining the biology of aging in plain language. That blog became the seed of VitMode. Today Anna oversees the entire editorial process, holding every piece to the same rigor her old lab demanded: primary sources, methodology checks, and honesty about the limits of the evidence. Outside work, she's a dedicated boulderer.

121 publications on this site

PZ

Medical review

dr Piotr Zieliński

Endocrinologist

Piotr has practiced endocrinology for more than fifteen years, mostly in male hormonal disorders and metabolic health. He joined VitMode as a scientific consultant because, as he jokes, he got tired of explaining the same testosterone questions at every appointment and decided to write the answers down properly, once. He reviews content on hormone therapy, supplement pharmacology and drug interactions, making sure articles never turn into encouragement to self-supplement in situations that genuinely need diagnostics and medical supervision. His professional motto — "evidence first, enthusiasm second" — has come up more than once with a patient who arrived with a supplement plan they found online.

174 publications on this site

Published: September 5, 2026Updated: September 5, 2026

Related entries

Minimalistyczna klepsydra z przesypującym się piaskiem4.2

Biological Age Clocks

An umbrella term covering very different methods for estimating the 'true' pace at which an organism is aging — from well-validated second-generation epigenetic clocks to far less proven commercial tests based on glycans or the microbiome. Not all of them carry a comparable level of evidence.

BiomarkeryModerate evidence
Osoba wykonująca wymaz z jamy ustnej za pomocą zestawu testowego4.0

OMAA Score

The OMAA Score (Oral Microbiome Aging Acceleration) is a numerical index calculated as the difference between the age predicted from an oral microbiome sample and a person's actual age — in the study that introduced it, it was linked to elevated mortality and frailty risk.

BiomarkeryEarly-stage evidence
Kolorowa, zróżnicowana ekspozycja świeżych warzyw na targu4.6

Gut Microbiome

Trillions of bacteria, viruses, and fungi colonizing the gut aren't a passive "passenger" in the body — they're an active ecosystem influencing digestion, immunity, and even mood, with an increasingly well-documented, though still not fully mapped, role in whole-body health.

MikrobiomModerate evidence
Dentystka badająca pacjenta w gabinecie stomatologicznym4.1

Oral Microbiome Aging

The composition of bacteria colonizing the mouth changes in a predictable way with age — predictable enough that researchers have started building models to estimate biological age from a simple saliva sample.

MikrobiomEarly-stage evidence
Skomplikowany obraz rezonansu magnetycznego mózgu na ekranie komputera4.2

Organ Biological Age

The concept that individual organs — the heart, brain, liver, or kidneys — can age at markedly different rates within the same person, measurable through analysis of tissue-specific plasma proteins rather than a single, averaged 'biological age' score.

BiomarkeryModerate evidence
Dłonie wykonujące test poziomu cukru we krwi glukometrem4.7

HbA1c (Glycated Hemoglobin)

A biomarker reflecting average blood glucose over the past 2–3 months — the gold standard for diagnosing and monitoring diabetes, far more stable than a single glucose measurement.

BiomarkeryStrong evidence
Naukowiec w stroju ochronnym przeprowadzający test z użyciem probówki4.1

Epigenetic Age Acceleration

The difference between an age estimated from a DNA methylation pattern and chronological age — one of the most statistically well-documented aging biomarkers, strongly linked to mortality in population studies, though still of limited diagnostic value for a single individual.

BiomarkeryModerate evidence

Related articles

Rzędy probówek z próbkami krwi w stojaku laboratoryjnymPoradniki

5 Biomarkers Worth Knowing Before 40 — Signals Before Symptoms Appear

A standard "once-a-year blood count" often misses early signs of metabolic and hormonal issues. Here are five markers worth asking your doctor about, before anything starts to hurt.

PZdr Piotr Zieliński7 min

August 1, 2026

Osoba jedząca naturalny jogurt ze słoika bambusową łyżeczkąPoradniki

Probiotics and Antibiotics: Do They Really Prevent Diarrhea?

This is one of the best-studied uses of probiotics — and one of the few cases where science points to a specific, best strain instead of a vague "probiotics help." We check how much the risk of antibiotic-associated diarrhea really drops, who benefits most, and which strain wins in head-to-head comparison.

PZdr Piotr Zieliński11 min

August 22, 2026

Kobieta w szlafroku aplikująca krem do twarzyPoradniki

Collagen and Skin Health: What Do Two Meta-Analyses Show?

Collagen powder or capsules are one of the fastest-growing segments of the beauty supplement market — and, rare for this category, one of the few where the popular promise ("firmer, better-hydrated skin") has earned solid confirmation in two independent, well-designed meta-analyses. This is a rare situation in supplement science, worth a closer look precisely because the evidence here is unusually consistent.

AKdr Anna Kowalczyk11 min

August 25, 2026

Starsza kobieta ćwicząca rozciąganie ramion nad morzemPoradniki

Taurine and Longevity — What Do We Know, and What Don't We Know Yet?

In 2023, the journal Science published a headline-making study: declining taurine levels with age may drive aging, and supplementing it extended lifespan in mice and improved health in monkeys. Headlines quickly turned this into a "fountain of youth," but the study's own authors end their paper by saying that "clinical trials in humans seem warranted." We explain exactly what was shown in animals, what was merely correlated in humans, and why those two things are not the same.

AKdr Anna Kowalczyk11 min

August 25, 2026

Comments (2)

  • KW

    Kasia W. 2 weeks ago

    Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.

  • MT

    Marek T. a month ago

    Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.